Center for Regenerative Medicine
+7 (906) 618 80 00

Treatment of lung cancer

The strategy for treating lung cancer and the prognosis of the outcome of the disease depend on the stage of the disease and the histological type of lung cancer (the structure and characteristics of cancer cells). For example, small cell lung cancer is more likely to be sensitive to chemotherapy and radiation therapy. And the hope of a cure for non-small cell lung cancer is associated with surgical treatment. However, from 30 to 50% of patients with lung cancer detection already have a malignant tumor of the same size and prevalence that does not allow oncologists to remove it.Metastasis of lung cancer into lymph nodes and distant organs is extremely unfavorable prognostically. Lifespan in these cases without treatment for about four months, and only 10% (one in ten patients) for more than one year.

When using the most modern schemes of polychemotherapy (cisplatin and carboplatin) in combination with Taxol, Gemcitabinr, Etoposide, Vinblastin, etc., life expectancy increases to 6-8 months, and in 20-25% of one patient out of four or five) over a year . However, with the use of chemotherapy, there are side effects, which are often individual and lead to a serious deterioration in the patient’s condition. The main manifestations of toxicity include neutropenia (76%) (the patient becomes vulnerable to any infections), thrombocytopenia (42%) (bleeding in patients with lung cancer) and diarrhea (13%). Therefore, before the appointment of a doctor, the doctor must carefully evaluate the patient’s condition, weigh the pros and cons before prescribing the appropriate course of treatment for lung cancer.

It should be noted that the treatment of lung cancer stage 4 (spread throughout the body of the tumor), especially non-small cell lung cancer, should be regarded only as palliative or symptomatic. There is already no hope for saving such patients from oncologists. Palliative care is medical care aimed at reducing suffering, prolonging and improving the quality of life of lung cancer patients who are considered incurable and are affected by malignant neoplasm. This is a forced approach, recognizing the impossibility of the existing arsenal of methods or medicines to defeat lung cancer. Palliative methods of treating lung cancer include anesthesia, oxygen therapy, detoxification, palliative surgery (imposition of tracheostomy, gastrostomy, enterostomy, nephrostomy, etc.). With cancerous pneumonia, anti-inflammatory treatment is performed, with pleural pleurisy — drainage of the pleural cavity, haemostatic therapy with pulmonary hemorrhage. Single recommendations for the comprehensive treatment of patients with lung cancer stage 4 (degree), unfortunately, no.
Absolutely obvious is the need for more effective methods of treatment.

With the use of modified biotherapy, according to Govallo, in most patients with a predicted lifetime (under the condition of specialized standard antitumor treatment) from several weeks to several months, it was possible to significantly prolong life. Patients have won at least six months. Some of them with such therapy — two years or more. The most important aspect of alternative biological treatment was the fact that the quality of life of patients with incurable cancer was much better than in the case of conventional standard palliative therapy of lung cancer with chemotherapy and radiation. Moreover, in a number of cases, a significant regression of the tumor was observed, and patients returned to full-fledged life.

Based on the method of Govallo, we developed a strategy for the creation of a new complex biopreparation, which has a predictable pronounced antitumor activity under the conditions of a study with prevalent malignant lung tumors, based on the mutually reinforcing effect of two components:

1.Inductor regression of malignant tumors.

2. Activator of antitumor reaction of local and systemic immunity.

The use of the biopreparation in the treatment of metastatic lung cancer demonstrates the effect of reversion of a part of tumor metastases against the background of gradual destruction (regression) of the primary focus of malignant neoplasm.

For a preliminary decision on the prospects of treating your disease, it is not necessary to come to the clinic personally. Send an extract from the medical history and all analyzes to the e-mail address or through the Record form on our website. Doctors will hold a consultation and decide on the expediency of your visit.